No connection

Search Results

BV

BEARISH
$13.21 Live
BrightView Holdings, Inc. · NYSE
Target $16.17 (+22.4%)
$11.06 52W Range $17.11

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$1.25B
P/E
101.61
ROE
3.1%
Profit margin
2.1%
Debt/Equity
0.53
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
78%
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and no available Altman Z-Score limits distress risk assessment. Despite a current Price/Book of 0.97 suggesting possible value appeal, the extremely high P/E of 101.62 and negative revenue growth paint a concerning picture. The company has consistently missed earnings estimates over the last four quarters with an average surprise of -55.92%, signaling deteriorating earnings quality. Combined with bearish insider activity and weak technicals, the stock appears fundamentally challenged despite a modest recovery in short-term price action.

Key Strengths

Price/Book ratio of 0.97 suggests the stock may be trading near book value, potentially offering a margin of safety.
Debt/Equity ratio of 0.53 indicates conservative leverage relative to sector average of 5.24.
Current and Quick Ratios (1.29 and 1.14) reflect adequate short-term liquidity.
Operating margin of 8.55% remains positive despite sector-wide margin pressure.
Analyst target price of $16.17 implies ~22% upside from current levels, indicating some external optimism.

Key Risks

Piotroski F-Score of 4/9 indicates weak financial health, particularly concerning given declining profitability and inconsistent earnings.
Extremely high trailing P/E of 101.62 suggests severe overvaluation or earnings collapse, especially when forward P/E is 15.05.
Revenue growth is negative YoY (-3.60%), indicating top-line contraction in a growing sector (avg 16.95%).
Consistent earnings misses: 0 out of last 4 quarters beaten with an average negative surprise of -55.92%.
Bearish insider activity: recent $0.44M in officer sales with no buys, signaling lack of confidence from management.
AI Fair Value Estimate
Based on comprehensive analysis
$6.32
-52.2% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
29
Weak
Value
42
Future
35
Past
30
Health
40
Dividend
0
AI Verdict
High risk, low confidence investment with weak fundamentals and inconsistent performance.
Key drivers: Low Piotroski F-Score, Negative earnings surprises, High trailing P/E, Bearish insider activity, Negative revenue growth
Confidence
75%
Value
42/100

Ref P/E, PEG, Graham Number

Positives
  • Price/Book of 0.97 near parity
  • Graham Number of $6.32 provides conservative value floor
Watchpoints
  • Trailing P/E of 101.62 is extremely high
  • Forward P/E of 15.05 not enough to justify current valuation
  • Price/Sales of 0.47 suggests low pricing power
Future
35/100

Ref Growth rates

Positives
  • Forward P/E implies earnings recovery expectations
  • Q/Q EPS growth of 8.20% shows short-term improvement
Watchpoints
  • Revenue growth YoY at -3.60%
  • No PEG ratio due to unreliable growth trajectory
  • Most recent Q/Q and YoY EPS growth both at -10.0%
Past
30/100

Ref Historical trends

Positives
  • Some past earnings beats (e.g., +128.4% in 2021)
Watchpoints
  • 4 of last 5 quarters missed estimates
  • Average surprise of -55.92% over last 4 quarters
  • Earnings volatility with multiple negative quarters
Health
40/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Piotroski F-Score of 4/9 is stable (not weak)
  • Debt/Equity of 0.53 is low
  • Current and Quick Ratios above 1.0
Watchpoints
  • No Altman Z-Score available raises transparency concerns
  • ROE of 3.13% and ROA of 2.96% are very low
  • Profit margin of 2.10% indicates weak profitability
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend yield or payout history
  • Dividend strength score of 0/100

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$13.21
Analyst Target
$16.17
Upside/Downside
+22.4%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BV and closest competitors.

Updated 2026-01-23
BV
BrightView Holdings, Inc.
Primary
5Y
-18.0%
3Y
+80.2%
1Y
-16.1%
6M
-18.8%
1M
+2.2%
1W
0.0%
ICF
ICF International, Inc.
Peer
5Y
-24.2%
3Y
-37.5%
1Y
-17.1%
6M
-21.6%
1M
-5.7%
1W
+0.7%
ENV
Enovix Corporation
Peer
5Y
-66.9%
3Y
-56.4%
1Y
+5.0%
6M
-54.7%
1M
+12.6%
1W
+15.3%
CDR
Cadre Holdings, Inc.
Peer
5Y
+103.3%
3Y
+45.8%
1Y
-1.0%
6M
-31.9%
1M
-8.6%
1W
-5.9%
WLF
Willis Lease Finance Corporation
Peer
5Y
+354.3%
3Y
+285.3%
1Y
+36.2%
6M
+47.7%
1M
+7.4%
1W
-6.7%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
101.61
Forward P/E
15.05
PEG Ratio
N/A
P/B Ratio
0.97
P/S Ratio
0.47
EV/Revenue
0.99
EV/EBITDA
7.93
Market Cap
$1.25B

Profitability

Profit margins and return metrics

Profit Margin 2.1%
Operating Margin 8.55%
Gross Margin 23.26%
ROE 3.13%
ROA 2.96%

Growth

Revenue and earnings growth rates

Revenue Growth -3.6%
Earnings Growth +6.3%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +8.2%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.53
Moderate
Current Ratio
1.29
Good
Quick Ratio
1.14
Good
Cash/Share
$0.79

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-03
$N/A
2025-11-19
$0.27
-14.7% surprise
2025-08-06
$0.3
-10.7% surprise
2025-05-07
$-0.03
-142.3% surprise

Industrials Sector Comparison

Comparing BV against 469 companies in the Industrials sector (39 bullish, 174 neutral, 256 bearish)
P/E Ratio
101.61
This Stock
vs
98.24
Sector Avg
+3.4% (Premium)
Return on Equity (ROE)
3.13%
This Stock
vs
-19.38%
Sector Avg
-116.1% (Below Avg)
Profit Margin
2.1%
This Stock
vs
6.65%
Sector Avg
-68.5% (Weaker)
Debt to Equity
0.53
This Stock
vs
2.63
Sector Avg
-79.9% (Less Debt)
Revenue Growth
-3.6%
This Stock
vs
71.29%
Sector Avg
-105.0% (Slower)
Current Ratio
1.29
This Stock
vs
3.09
Sector Avg
-58.1% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

BOMBA-OKUN JANE L
Director
Stock Award
2025-12-31
2,170 shares · $27,494
LOPEZ FRANCISCO JR.
Director
Stock Award
2025-12-31
2,042 shares · $25,872
CORNOG WILLIAM L.
Director
Stock Award
2025-12-31
1,825 shares · $23,123
SWAN MARA E
Director
Stock Award
2025-12-31
2,071 shares · $26,240
CORNOG WILLIAM L.
Director
Buy
2025-12-02
10,000 shares · $128,400
ORDERS AMANDA MARIE
Officer
Stock Award
2025-12-02
4,688 shares
URBAN BRETT NICHOLAS
Chief Financial Officer
Stock Award
2025-12-02
7,934 shares
JACKSON BRIAN EDWARD
Officer
Stock Award
2025-12-02
1,082 shares
DOZIER MICHAEL JOE
Officer
Stock Award
2025-12-02
3,967 shares
GOTTSEGEN JONATHAN MARK
Officer
Stock Award
2025-12-02
5,381 shares
ASPLUND DALE A
Chief Executive Officer
Stock Award
2025-12-02
28,851 shares
GOTTSEGEN JONATHAN MARK
Officer
Sell
2025-12-01
35,000 shares · $441,700
DOZIER MICHAEL JOE
Officer
Stock Award
2025-11-18
34,090 shares
GOTTSEGEN JONATHAN MARK
Officer
Stock Award
2025-11-18
49,866 shares
ORDERS AMANDA MARIE
Officer
Stock Award
2025-11-18
40,106 shares
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
9 analysts
Morgan Stanley
2025-12-17
Maintains
Equal-Weight Equal-Weight
Morgan Stanley
2025-11-21
Maintains
Equal-Weight Equal-Weight
Goldman Sachs
2025-11-21
Maintains
Sell Sell
Baird
2025-11-20
Maintains
Outperform Outperform

Past News Coverage

Recent headlines mentioning BV from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile